Sol-Gel Technologies Ltd. (SLGL) stock
SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$53.36+0.53 (+1.00%)
Close on Nov 18, 2026Market cap $148.67MP/E –Yield –
Sol-Gel Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$7.54M. The highest annual figure on record is $2.96M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.54M | – |
| FY2024 | Dec 31, 2024 | -$12.01M | – |
| FY2023 | Dec 31, 2023 | -$29.31M | – |
| FY2022 | Dec 31, 2022 | -$16.24M | -648.0% |
| FY2021 | Dec 31, 2021 | $2.96M | – |
| FY2020 | Dec 31, 2020 | -$30.23M | – |
| FY2019 | Dec 31, 2019 | -$25.95M | – |
| FY2018 | Dec 31, 2018 | -$33.52M | – |
| FY2017 | Dec 31, 2017 | -$31.63M | – |
| FY2016 | Dec 31, 2016 | -$20.76M | – |
| FY2015 | Dec 31, 2015 | -$9.65M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.16M | – |
| Q2 FY2025 | Jun 30, 2025 | $11.23M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$463.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$8.04M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.55M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.29M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.29M | – |
See a number that looks wrong?